Affymetrix, Inc. (NASDAQ:AFFX) announced a co-marketing agreement today naming GenoSplice, Inc. as its preferred data analysis service provider for the new GeneChip® Human Transcriptome Array 2.0, the most comprehensive microarray available for alternative splicing detection. GenoSplice, a leader in genomic data analysis and alternative splicing, has developed a dedicated expression analysis solution, EASANA ®, including analysis for Affymetrix’ microarrays, such as GeneChip ® Exon 1.0 ST Array, GeneChip ® Human Transcriptome Array 1.0, and the new GeneChip ® Human Transcriptome Array 2.0. When combined with GenoSplice analysis services, these arrays provide the highest resolution profiling of the transcriptome available on a microarray at both the gene and exon level.
“As part of Affymetrix’ commitment to provide end-to-end solutions, we are enabling those without access to bioinformatics to utilize the most powerful microarrays ever developed for the interrogation of alternative splicing events. Now with so many options open to researchers, it is increasingly more important to provide tools that generate biologically relevant results, not just data,” commented Kevin Cannon, SVP – Expression Business Unit at Affymetrix.
“We’re pleased to work with Affymetrix to combine two very powerful tools, Affymetrix’ high resolution microarrays for gene expression profiling of transcript isoforms and GenoSplice’s proprietary transcriptome data analysis service, to help researchers save valuable time so they can focus on the biology instead of on analytical details,” said Marc Rajaud, Co-CEO of GenoSplice. “GeneChip ® Human Transcriptome Array 2.0 increases accessibility to genomic research, resulting in new data that have to be interpreted to be useful. Collaborating with Affymetrix helps keep GenoSplice on the forefront of developing dedicated tools that streamline and simplify genomic data analysis.”
PLEASE NOTE: Affymetrix ®, the Affymetrix logo, and GeneChip ® trademarks are the property of Affymetrix, Inc. All other trademarks are the property of their respective owners.Products mentioned in this release are For Research Use only. Not for diagnostic procedures.